Implementation notice: Two new transplant performance metrics now in effect
July 14, 2022
New metrics will provide a more holistic view of patient care, are expected to reduce emphasis on post-transplant outcomes and increase the number of transplants.
New exception pathway available for heart device recalls
July 14, 2022
In order to address patient safety concerns, the OPTN Executive Committee approved a modification of OPTN Policy 6.4: Adult and Pediatric Status Exceptions on July 11 that is now in effect.
Emergency action: New exception pathway for heart device recalls
July 11, 2022
This new policy will allow transplant programs to submit an exception request on behalf of adult heart transplant candidates for a Status 1, 2 or 3 exception without requiring hospitalization if the FDA has recalled their implanted mechanical circulatory support device.
COVID-19 update: July 8, 2022
July 8, 2022
CDC’s interim recommendations for Moderna and Pfizer-BioNTech vaccines for children from 6 months of age; FDA recommends Omicron BA.4/5 component for vaccine boosters
One-year monitoring report shows increases in kidney transplants for Black, Hispanic, Asian and pediatric patients following policy changes
July 1, 2022
Report captures first 12 months of data after implementation of 250 nautical mile circles.
Implementation notice: Pre-transplant HIV, HBV and HCV testing requirement updated for candidates younger than age 12
July 1, 2022
Effective July 1, testing no longer required for HIV, HBV and HCV at the time of hospital admission for transplant candidates younger than age 12.
Page 45 of 290
